Agonist ligands mediate the transcriptional response of nuclear receptor heterodimers through distinct stoichiometric assemblies with coactivators

Journal of Biological Chemistry

Volumn 289, Issue 36, 2014, Pages 24771-24778

  Pavlin, Mark Remec ^a,c   Brunzelle, Joseph S ^b   Fernandez, Elias J ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING SITES; MOLECULES; PROTEINS; TRANSCRIPTION; X RAY SCATTERING;

ANALYTICAL ULTRACENTRIFUGATION; CO-ACTIVATOR BINDING SITES; MEDIATED TRANSCRIPTION; SEDIMENTATION COEFFICIENTS; SMALL ANGLE X-RAY SCATTERING; STEROID RECEPTOR COACTIVATOR-1; TRANSCRIPTION ASSAYS; TRANSCRIPTIONAL RESPONSE;

LIGANDS;

CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; RETINOID X RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; CELL RECEPTOR; LIGAND; PROTEIN BINDING; RETINOID X RECEPTOR ALPHA;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; MOLECULAR WEIGHT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; RADIATION SCATTERING; REGULATORY MECHANISM; STOICHIOMETRY; TRANSACTIVATION; TRANSCRIPTION REGULATION; ULTRACENTRIFUGATION; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; MUTATION; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; SMALL ANGLE SCATTERING; TRANSCRIPTION INITIATION; X RAY DIFFRACTION;

ANIMALS; BINDING SITES; CELL LINE; HUMANS; LIGANDS; MICE; MODELS, MOLECULAR; MOLECULAR WEIGHT; MUTATION; NUCLEAR RECEPTOR COACTIVATOR 1; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINOID X RECEPTOR ALPHA; SCATTERING, SMALL ANGLE; TRANSCRIPTIONAL ACTIVATION; X-RAY DIFFRACTION;

EID: 84906960108     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.575423     Document Type: Article

References (60)

1. Rosenfeld, M. G., and Glass, C. K. (2001) Coregulator codes of transcriptional regulation by nuclear receptors. J. Biol. Chem. 276, 36865-36868
2. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R. M. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839
3. Billas, I., and Moras, D. (2013) Allosteric controls of nuclear receptor function in the regulation of transcription. J. Mol. Biol. 425, 2317-2329
4. Onate, S. A., Boonyaratanakornkit, V., Spencer, T. E., Tsai, S. Y., Tsai, M. J., Edwards, D. P., and O'Malley, B. W. (1998) The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J. Biol. Chem. 273, 12101-12108
5. Shulman, A. I., Larson, C., Mangelsdorf, D. J., and Ranganathan, R. (2004) Structural determinants of allosteric ligand activation in RXR heterodimers. Cell 116, 417-429
6. Forman, B. M., Umesono, K., Chen, J., and Evans, R. M. (1995) Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81, 541-550
7. Putcha, B. D., Wright, E., Brunzelle, J. S., and Fernandez, E. J. (2012) Structural basis for negative cooperativity within agonist-bound TR:RXR heterodimers. Proc. Natl. Acad. Sci. U.S.A. 109, 6084-6087
8. Rochel, N., Ciesielski, F., Godet, J., Moman, E., Roessle, M., Peluso-Iltis, C., Moulin, M., Haertlein, M., Callow, P., Mély, Y., Svergun, D. I., and Moras, D. (2011) Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings. Nat. Struct. Mol. Biol. 18, 564-570
9. Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., and Moore, D. D. (2000) The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407, 920-923
10. Zhang, J., Huang, W., Chua, S. S., Wei, P., and Moore, D. D. (2002) Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 298, 422-424
11. Sonoda, J., Rosenfeld, J. M., Xu, L., Evans, R. M., and Xie, W. (2003) A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection. Curr. Drug Metab. 4, 59-72
12. Huang, W., Zhang, J., Chua, S. S., Qatanani, M., Han, Y., Granata, R., and Moore, D. D. (2003) Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. U.S.A. 100, 4156-4161
13. Baes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D., and Moore, D. D. (1994) A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell. Biol. 14, 1544-1552
14. Choi, H. S., Chung, M., Tzameli, I., Simha, D., Lee, Y. K., Seol, W., and Moore, D. D. (1997) Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J. Biol. Chem. 272, 23565-23571
15. Dussault, I., Lin, M., Hollister, K., Fan, M., Termini, J., Sherman, M. A., and Forman, B. M. (2002) A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity. Mol. Cell. Biol. 22, 5270-5280
16. Suino, K., Peng, L., Reynolds, R., Li, Y., Cha, J. Y., Repa, J. J., Kliewer, S. A., and Xu, H. E. (2004) The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol. Cell 16, 893-905
17. Xu, R. X., Lambert, M. H., Wisely, B. B., Warren, E. N., Weinert, E. E., Waitt, G. M., Williams, J. D., Collins, J. L., Moore, L. B., Willson, T. M., and Moore, J. T. (2004) A structural basis for constitutive activity in the human CAR/RXRα heterodimer. Mol. Cell 16, 919-928
18. Tzameli, I., Pissios, P., Schuetz, E. G., and Moore, D. D. (2000) The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol. Cell. Biol. 20, 2951-2958
19. Maglich, J. M., Parks, D. J., Moore, L. B., Collins, J. L., Goodwin, B., Billin, A. N., Stoltz, C. A., Kliewer, S. A., Lambert, M. H., Willson, T. M., and Moore, J. T. (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 278, 17277-17283
20. Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., Kratzeisen, C., Rosenberger, M., and Lovey, A. (1992) 9-cis-Retinoic acid stereoisomer binds and activates the nuclear receptor RXR α. Nature 355, 359-361
21. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S. C., Heyman, R. A., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414
22. Yao, T. P., Ku, G., Zhou, N., Scully, R., and Livingston, D. M. (1996) The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. U.S.A. 93, 10626-10631
23. Spencer, T. E., Jenster, G., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Onate, S. A., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389, 194-198
24. Wright, E., Vincent, J., and Fernandez, E. J. (2007) Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry. Biochemistry 46, 862-870
25. Wright, E., Busby, S. A., Wisecarver, S., Vincent, J., Griffin, P. R., and Fernandez, E. J. (2011) Helix 11 dynamics is critical for constitutive androstane receptor activity. Structure 19, 37-44
26. Konarev, P. V., Petoukhov, M. V., Volkov, V. V., and Svergun, D. I. (2006) ATSAS 2.1, a program package for small-angle scattering data analysis. J. Appl. Crystallogr. 39, 277-286
27. Svergun, D. I. (1999) Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J. 76, 2879-2886
28. Receveur-Brechot, V., and Durand, D. (2012) How random are intrinsically disordered proteins? A small angle scattering perspective. Curr. Protein Pept. Sci. 13, 55-75
29. Rambo, R. P., and Tainer, J. A. (2013) Accurate assessment of mass, models and resolution by small-angle scattering. Nature 496, 477-481
30. Schuck, P. (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78, 1606-1619
31. Shan, L., Vincent, J., Brunzelle, J. S., Dussault, I., Lin, M., Ianculescu, I., Sherman, M. A., Forman, B. M., and Fernandez, E. J. (2004) Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism. Mol. Cell 16, 907-917
32. Welch, B. L. (1947) The generalization of students problem when several different population variances are involved. Biometrika 34, 28-35
33. Westin, S., Rosenfeld, M. G., and Glass, C. K. (2000) Nuclear receptor coactivators. Adv. Pharmacol. 47, 89-112
34. Leo, C., and Chen, J. D. (2000) The SRC family of nuclear receptor coactivators. Gene 245, 1-11
35. Lonard, D. M., and O'Malley, B. W. (2012) Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nat. Rev. Endocrinol. 8, 598-604
36. Millard, C. J., Watson, P. J., Fairall, L., and Schwabe, J. W. (2013) An evolving understanding of nuclear receptor coregulator proteins. J. Mol. Endocrinol. 51, T23-T36
37. Johnson, A. B., and O'Malley, B. W. (2012) Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy. Mol. Cell Endocrinol. 348, 430-439
38. Wurtz, J. M., Bourguet, W., Renaud, J. P., Vivat, V., Chambon, P., Moras, D., and Gronemeyer, H. (1996) A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3, 87-94
39. Schulman, I. G., Chakravarti, D., Juguilon, H., Romo, A., and Evans, R. M. (1995) Interactions between the retinoid X receptor and a conserved region of the TATA-binding protein mediate hormone-dependent transactivation. Proc. Natl. Acad. Sci. U.S.A. 92, 8288-8292
40. Schulman, I. G., Li, C., Schwabe, J. W., and Evans, R. M. (1997) The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. Genes Dev. 11, 299-308
41. Thompson, P. D., Remus, L. S., Hsieh, J. C., Jurutka, P. W., Whitfield, G. K., Galligan, M. A., Encinas Dominguez, C., Haussler, C. A., and Haussler, M. R. (2001) Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts. J. Mol. Endocrinol. 27, 211-227
42. Ito, M., Fukuzawa, K., Mochizuki, Y., Nakano, T., and Tanaka, S. (2008) Ab initio fragment molecular orbital study of molecular interactions between liganded retinoid X receptor and its coactivator; part II: influence of mutations in transcriptional activation function 2 activating domain core on the molecular interactions. J. Phys. Chem. A 112, 1986-1998
43. Germain, P., Iyer, J., Zechel, C., and Gronemeyer, H. (2002) Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415, 187-192
44. Lou, X., Toresson, G., Benod, C., Suh, J. H., Philips, K. J., Webb, P., and Gustafsson, J. A. (2014) Structure of the retinoid X receptor α-liver X receptor β (RXRα-LXRβ) heterodimer on DNA. Nat. Struct. Mol. Biol. 21, 277-281
45. Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T. P., and Rastinejad, F. (2008) Structure of the intact PPAR-γ-RXR-α nuclear receptor complex on DNA. Nature 456, 350-356
46. Heery, D. M., Kalkhoven, E., Hoare, S., and Parker, M. G. (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736
47. Kalkhoven, E., Valentine, J. E., Heery, D. M., and Parker, M. G. (1998) Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J. 17, 232-243
48. Perlmann, T., Rangarajan, P. N., Umesono, K., and Evans, R. M. (1993) Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev. 7, 1411-1422
49. Kurokawa, R., Yu, V. C., Näär, A., Kyakumoto, S., Han, Z., Silverman, S., Rosenfeld, M. G., and Glass, C. K. (1993) Differential orientations of the DNA-binding domain and carboxyl-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev. 7, 1423-1435
50. Zechel, C., Shen, X. Q., Chen, J. Y., Chen, Z. P., Chambon, P., and Gronemeyer, H. (1994) The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J. 13, 1425-1433
51. Li, X., Wong, J., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. (2003) Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol. Cell. Biol. 23, 3763-3773
52. Westin, S., Kurokawa, R., Nolte, R. T., Wisely, G. B., McInerney, E. M., Rose, D. W., Milburn, M. V., Rosenfeld, M. G., and Glass, C. K. (1998) Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 395, 199-202
53. Osz, J., Brélivet, Y., Peluso-Iltis, C., Cura, V., Eiler, S., Ruff, M., Bourguet, W., Rochel, N., and Moras, D. (2012) Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors. Proc. Natl. Acad. Sci. U.S.A. 109, E588-E594
54. Wu, Z., and Boss, O. (2007) Targeting PGC-1 α to control energy homeostasis. Expert. Opin. Ther. Targets 11, 1329-1338
55. Hwang, J. Y., Attia, R. R., Zhu, F., Yang, L., Lemoff, A., Jeffries, C., Connelly, M. C., and Guy, R. K. (2012) Synthesis and evaluation of sulfonylnitrophenylthiazoles (SNPTs) as thyroid hormone receptor-coactivator interaction inhibitors. J. Med. Chem. 55, 2301-2310
56. Ding, X. F., Anderson, C. M., Ma, H., Hong, H., Uht, R. M., Kushner, P. J., and Stallcup, M. R. (1998) Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 12, 302-313
57. Gill, R. Q., and Sterling, R. K. (2001) Acute liver failure. J. Clin. Gastroenterol. 33, 191-198
58. de Urquiza, A. M., Liu, S., Sjöberg, M., Zetterström, R. H., Griffiths, W., Sjövall, J., and Perlmann, T. (2000) Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290, 2140-2144
59. Lengqvist, J., Mata De Urquiza, A., Bergman, A. C., Willson, T. M., Sjövall, J., Perlmann, T., and Griffiths, W. J. (2004) Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor α ligand-binding domain. Mol. Cell Proteomics 3, 692-703
60. Volakakis, N., Joodmardi, E., and Perlmann, T. (2009) NR4A orphan nuclear receptors influence retinoic acid and docosahexaenoic acid signaling via up-regulation of fatty acid binding protein 5. Biochem. Biophys. Res. Commun. 390, 1186-1191